APOE and Alzheimer disease: Early detection of AD should employ multimodal approaches that consider genetic burden (such as the APOE and PICALM risks in our study), and additionally some or all markers like blood-based biomarkers, MRI/fMRI/EEG abnormalities, cognitive performance, health, lifestyle, demographic factors, and neuropsychological assessments.